Floatz logo

Immunoglobulin G1, anti-(human neuregulin receptor HER3) (human monoclonal U3-1287 heavy chain), disulfide with human monoclonal U3-1287 ?-chain, dimer

NSCLC (Advanced Non-small Cell Lung Cancer)

Daiichi Sankyomonoclonal_antibodyPhase 3Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
39/ 100
Competitive Position
81/ 100

Competitive context

1206 Active assets in the NSCLC (Advanced Non-small Cell Lung Cancer) cohort.

Asset / SponsorPhaseRating
Necitumumab
Jonsson Comprehensive Cancer Center
Phase 3BBB
Zorifertinib
Alpha Biopharma (Jiangsu) Co., Ltd.
Phase 2/3BBB
Glumetinib
Shanghai JMT-Bio Inc.
Phase 3BBB
d-0316
Betta Pharmaceuticals Co., Ltd.
Phase 2/3BBB
Onartuzumab
Hoffmann-La Roche
Phase 3BBB

View all 50 →

Same molecule, other indications

Immunoglobulin G1, anti-(human neuregulin receptor HER3) (human monoclonal U3-1287 heavy chain), disulfide with human monoclonal U3-1287 ?-chain, dimer is also rated in:

triple-negative breast carcinomaDormant
CC
Indicative ·
46 / 100
View asset →
angiosarcomaDormant
CC
Indicative ·
46 / 100
View asset →
Hormone Receptor Positive TumorDormant
CC
Indicative ·
46 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →